These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7542770)

  • 21. Effects of the cholecystokinin A receptor antagonist loxiglumide on the proliferation and cell cycle time of pancreatic acinar cells in rats.
    Kanemitsu D; Sakagami J; Motoyoshi T; Nakajima T; Kataoka K
    Pancreas; 2006 Mar; 32(2):190-6. PubMed ID: 16552340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
    Varga G; Papp M; Scarpignato C
    Fundam Clin Pharmacol; 1989; 3(3):295-306. PubMed ID: 2475419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous and cholecystokinin-octapeptide-promoted regeneration of the pancreas following L-arginine-induced pancreatitis in rat.
    Hegyi P; Takács T; Jármay K; Nagy I; Czakó L; Lonovics J
    Int J Pancreatol; 1997 Dec; 22(3):193-200. PubMed ID: 9444550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
    Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
    Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duration and potency of anticholecystokinin action of subcutaneous and oral loxiglumide on cerulein-stimulated pancreatic exocrine secretion.
    Watanabe N; Otsuki M
    Int J Pancreatol; 1993 Apr; 13(2):129-37. PubMed ID: 8501354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A; Kulesza E; Konturek SJ
    Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholecystokinin antagonist prevents hyperamylasemia and improves pancreatic exocrine function in cerulein-induced acute pancreatitis.
    Murayama KM; Drew JB; Nahrwold DL; Joehl RJ
    Pancreas; 1990 Jul; 5(4):439-44. PubMed ID: 1696383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
    Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A
    Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasting prevents acute pancreatitis induced by cerulein in rats.
    Otsuki M; Tani S; Okabayashi Y; Fujii M; Nakamura T; Fujisawa T; Koide M; Itoh H
    Dig Dis Sci; 1990 Jul; 35(7):840-8. PubMed ID: 2364838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin stimulated pancreatic enzyme secretion in man.
    Jebbink MC; Jansen JB; Mooy DM; Rovati LC; Lamers CB
    Regul Pept; 1991 Feb; 32(3):361-8. PubMed ID: 1714084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs.
    Niebergall-Roth E; Teyssen S; Wetzel D; Hartel M; Beglinger C; Riepl RL; Singer MV
    Scand J Gastroenterol; 1996 Jul; 31(7):723-32. PubMed ID: 8819225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of lorglumide (CR-1409) on pancreatic secretory and trophic response to caerulein in newborn rats.
    Papp M; Varga G; Folly G
    Acta Physiol Hung; 1991; 78(1):61-7. PubMed ID: 1722380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the CCK-antagonist loxiglumide on bile-induced experimental pancreatitis.
    Leonhardt U; Seidensticker F; Fussek M; Stöckmann F; Creutzfeldt W
    Int J Pancreatol; 1991 Sep; 10(1):73-80. PubMed ID: 1757732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic profile of TS-941, a new benzodiazepine derivative cholecystokinin-receptor antagonist, in in vitro isolated rat pancreatic acini.
    Tashiro M; Hirohata Y; Kihara Y; Akiyama T; Otsuki M
    Pancreas; 1999 Mar; 18(2):156-64. PubMed ID: 10090413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of endogenous cholecystokinin in pancreatic regeneration after cerulein-induced acute pancreatitis.
    Jurkowska G; Grondin G; Morisset J
    Pancreas; 1992; 7(3):295-304. PubMed ID: 1594550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exocrine pancreatic function in rats after acute pancreatitis.
    Czakó L; Yamamoto M; Otsuki M
    Pancreas; 1997 Jul; 15(1):83-90. PubMed ID: 9211497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCK receptor antagonist loxiglumide alters uptake of CCK in perfused liver and pancreatic acini of the rat.
    Beckh K; Göke R; Ruff W; Koop I; Arnold R; Adler G
    Digestion; 1991; 48(2):98-103. PubMed ID: 1868975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a new cholecystokinin receptor antagonist CR 1392 on caerulein-induced acute pancreatitis in rats.
    Otsuki M; Tani S; Okabayshi Y; Nakamura T; Fujii M; Fujisawa T; Baba S; Itoh H
    Pancreas; 1989; 4(2):237-43. PubMed ID: 2474165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans.
    Adler G; Beglinger C; Braun U; Reinshagen M; Koop I; Schafmayer A; Rovati L; Arnold R
    Gastroenterology; 1991 Feb; 100(2):537-43. PubMed ID: 1702077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.